2024-11-21-莱坊-M25_Offices_Q3_2024_7页_2mb

报告摘要

Investment & Development: Private money dominates the investment scene, with prime yields stabilizing at 7% despite higher borrowing costs. Investment volumes reached £237m, with private equity accounting for 38% of activity.
Occupier Market: Increased corporatedemand drives lease volumes, consolidating fragmented footprints into prime locations. New & Grade A vacancy dipped to 6.4%, the highest in 24 months, due to supply constraints.
Prime Rents & Leasing: Prime rent levels remain stable at £7/psq ft. High-quality space remains scarce, leading to record deals and sustained bidding competition.
Supply & Pipeline: Development pipeline is concentrated (4.5m sq ft speculative by Q3 2024), with West London leading new delivery. Availability has stabilized compared to previous quarters.
Investor Trends: Corporate & institutional activity is cautious due to financing constraints. Activity is shifting towards prime assets with modernization potential.
Market Shifts: Demand from TMT, Life Sciences & Healthcare leads seats demand. Venue flexibility and remote working continue as key drivers.
Transaction Status: Key deals (e.g., Chiswick, Brentford) solidify market confidence. Interest rates and economic policies are key risks.

Investment activity cautious due to high debt costs and lack of motivated sellers.
Year-to-date (YTD) investment £217m (prior year £46m), with prime yields holding steady at 7%.
Focus is shifting to assets with repositioning potential as secondary yields remain lagged.

Tenants actively seeking prime space amidst remote-working transition.
Deal completion volumes (79 deals + 866k sq ft) meet 2024 expectations.
High-quality space scarcity fuels demand, with vacancy rates falling slightly except in secondary areas.

Prime rent levels stable, with demand concentrated in major hubs like Cambridge and London.
Significant transactions including MediaWork at £55/pSF (White City) and Vinci UK (£40/pSF, Watford).

New build pipeline significant (1.8m sq ft due for delivery by Q4 2024).
Supply constraints fuel prime demand and potential price appreciation as vacancy rates stabilize.

Economic volatility through higher borrowing costs limiting investment opportunities.
Leading occupiers (TMT, Healthcare, Life Sciences) driving market recovery and emphasis on flexible environments.
Institutional capital absence in the active purchaser base, limiting market pace.

展开完整摘要